HOME >> News

PRINT

NEWS
  • Japan Tissue Engineering Co., Ltd.
    6-209-1 Miyakitadori
    Gamagori, AICHI 443-0022
    TEL. +81-533-66-2020
    FAX. +81-533-66-2019
    Email) jtec-info@jpte.co.jp

NEWS

2017
Nov. 9, 2017 J-TEC provides CDMO and CRO services for Cyfuse Biomedical K.K. (Regenerative Medicine Venture Company that Fujifilm invests in.)
Nov. 1, 2017 Updated Top Message.
Oct. 30, 2017 Released "Financial Report for the 2 nd Quarter of FY2017".
Oct. 30, 2017 Updated Top Message.
Sep.27, 2017 J-TEC provides CDMO and CRO services for NC Medical Research, Inc. (Regenerative Medicine Venture Company that Fujifilm invests in.)
Aug. 23, 2017 Released Custom Development & Manufacturing Business contents.
Jul. 28, 2017 Released "Financial Report for the 1 st Quarter of FY2017".
Jun. 28, 2017 Updated Top Message.
May.10, 2017 J-TEC provides CDMO and CRO services for Regcell Co., Ltd. (Regenerative Medicine Venture Company that Fujifilm invests in.)
Apr. 3, 2017 Updated Top Message.
Jan. 30, 2017 Released "Financial Report for the 3 rd Quarter of FY2016".
Jan. 5, 2017 Updated Top Message.
2016
Oct. 28, 2016 Released "Financial Report for the 2nd Quarter of FY2016".
Updated Top Message.
Jul. 27, 2016 Released "Financial Report for the 1 st Quarter of FY2016".
Jun. 24, 2016 Updated Top Message.
The Annual J-TEC Stockholders Meeting took place on June 23th, and the Meeting approved the new BOD members. Updated Corporate Profile.
May 20, 2016 Notice Regarding Change in President and CEO
Apr. 27, 2016 Released "FY2015 Financial Report".
Apr. 1, 2016 Updated Top Message.
Jan. 29, 2016 Released "Financial Report for the 3 rd Quarter of FY2015".
Jan. 4, 2016 Updated Top Message.
2015
Nov. 2, 2015 Notification of the passing of Dr. Howard Green - In commemoration of Dr. Green -
Oct. 30, 2015 Released "Financial Report for the 2nd Quarter of FY2015".
Updated Financial Highlight.
Updated Top Message.
Oct. 13, 2015 Japan Tissue Engineering provides support to rescue victims of Taiwan water park explosion Autologous cultured epidermis JACE® treatment for severe burn victims ( PDF file 48KB)
Jul. 30, 2015 Released "Financial Report for the 1 st Quarter of FY2015".
Updated Financial Highlight.
Jun. 25, 2015 Updated Top Message.
The Annual J-TEC Stockholders Meeting took place on June 24th, and the Meeting approved the new BOD members. Updated Corporate Profile.
Apr. 30, 2015 Released "FY2014 Financial Report".
Updated Financial Highlight.
Apr. 1, 2015 Updated Top Message.
Jan. 30, 2015 Released "Financial Report for the 3 rd Quarter of FY2014".
Updated Financial Highlight.
Jan. 5, 2015 Updated Top Message.
2014
Dec. 18, 2014 Notice Concerning Change in Parent Company
Nov. 5, 2014 Updated Top Message.
Oct. 30, 2014 Notification Regarding the Exercise of Subscription Rights Through Private Allocation to a Third Party
Released "Financial Report for the 2 st Quarter of FY2014".
Updated Financial Highlight.
Oct. 14, 2014 Started multicenter clinical trials of autologous cultured corneal epithelium.
Aug. 2014 Awarded the 12th Award for Persons of Merit in Industry-Academia-Government Collaboration (Minister of Health, Labour and Welfare Prize).
Jul. 30, 2014 Released "Financial Report for the 1 st Quarter of FY2014".
Updated Financial Highlight.
Jun. 25, 2014 Updated Top Message.
Apr. 30, 2014 Released "FY2013 Financial Report".
Updated Financial Highlight.
Apr. 1, 2014 Updated Top Message.
Mar. 18, 2014 Notice Concerning Issue of Subscription Rights Through Private Allocation.
Updated IR Calendar.
Jan. 30, 2014 Released "Financial Report for the 3 rd Quarter of FY2013".
Updated Financial Highlight.
Jan. 6, 2014 Updated Top Message.
Awarded the 2013 Nikkei Superior Products and Services Awards: Nikkei Awards for Excellence.
2013
Oct. 30, 2013 Released "Financial Report for the 2nd Quarter of FY2013".
Updated Financial Highlight.
Updated Top Message.
Sept. 13, 2013 Awarded the 5th MONOZUKURI Manufacturing Japan Grand Awards: Prime Minister’s Prize.
Jul. 30, 2013 Released "Financial Report for the 1 st Quarter of FY2013".
Updated Financial Highlight.
Jul. 26, 2013 LabCyte CORNEA-MODEL
Jun. 26, 2013 Updated Top Message.
Apr. 30, 2013 Released "FY2012 Financial Report".
Updated Financial Highlight.
Apr. 1, 2013 Updated Top Message.
Autologous Cultured Cartilage “JACC”: Listed as an item covered by the National Health Insurance in Japan.
Jan. 30, 2013 Released "Financial Report for the 3 rd Quarter of FY2012".
Updated Financial Highlight.
Jan. 7, 2013 Updated Top Message.
2012
Oct. 30, 2012 Released "Financial Report for the 2nd Quarter of FY2012".
Updated Financial Highlight.
Updated Top Message.
Jun. 30, 2012 J-TEC Received Government Approval to Manufacture and Sell Autologous Cultured Cartilage JACC® in Japan ( PDF file 54KB)
Jul. 27, 2012 Released "Financial Report for the 1st Quarter of FY2012".
Updated Financial Highlight.
Jun. 27, 2012 Updated Top Message.
Apr. 27, 2012 Released "FY2011 Financial Report".
Updated Financial Highlight.
Apr. 2, 2012 Updated Top Message.
Mar. 22, 2012 Updated LabCyte EPI-MODEL - R&D Support Business - .
Jan. 31, 2012 Released "Financial Report for the 3 rd Quarter of FY2011".
Updated Financial Highlight.
Jan. 5, 2012 Updated Top Message.
2011
Oct. 28, 2011 Released "Financial Report for the 2nd Quarter of FY2011".
Updated Financial Highlight.
Updated Top Message.
Jul. 29, 2011 Released "Financial Report for the 1st Quarter of FY2011".
Updated Financial Highlight.
Jun. 24, 2011 Updated Top Message.
Apr. 28, 2011 Released "FY2010 Financial Report".
Updated Financial Highlight.
Apr. 1, 2011 Updated Top Message.
Jan. 31, 2011 Released "Financial Report for the 3rd Quarter of FY2010".
Updated Financial Highlight.
Jan. 5, 2011 Updated Top Message.
Posted Messages in the Past.
2010
Dec. 1, 2010 Announcement: Opening of Singapore Representative Office ( PDF file 128KB)
Oct. 28, 2010 Released "Financial Report for the 2nd Quarter of FY2010".
Updated Financial Highlight.
Updated Top Message.
Sep. 15, 2010 Announcement: Establishment of a Representative Office in Singapore ( PDF file 116KB)
Sep. 2, 2010 Updated Top Message.
Aug. 30, 2010 Announcement Regarding Issuance of New Shares by Third Party Allocation, and a Change in the Largest Shareholder ( PDF file 135KB)
Jul. 30, 2010 Released "Financial Report for the 1st Quarter of FY2010".
Updated Financial Highlight.
Jun. 23, 2010 Updated Top Message.
The Annual J-TEC Stockholders Meeting took place on June 22nd, and the Meeting approved the new BOD members. Updated Corporate Profile.
Apr. 30, 2010 Released "Financial Report for the FY2009".
Updated Financial Highlight.
Website Renewal
Apr. 1, 2010 Updated Top Message.
Jan. 29, 2010 Released "Financial Report for the 3rd Quarter of FY2009".
Updated Financial Highlight.
Jan. 5, 2010 Updated Top Message.
2009
Oct. 30, 2009 Released "Financial Report for the 2nd Quarter of FY2009".
Updated Top Message, and Financial Highlight.
Aug. 24, 2009 ANNOUNCEMENT: J-TEC HAS SUBMITTED AN APPLICATION FOR MANUFACTURING AND SALES OF AUTOLOGOUS CULTURED CARTILAGE ( PDF file 53kB)
Aug. 7, 2009 Newly registered at IR STREET.COM.
Jul. 30, 2009 Released "Financial Report for the 1st Quarter of FY2009".
Updated Financial Highlight.
Jul. 3, 2009 See the "Diagnostic Report on Hidden Potential" ( PDF file 1.6MB). This diagnostic report on J-TEC’s hidden company potential has been prepared by an analyst from Actcell Corporation, an intellectual capital consulting company.
Jun. 24, 2009 The Annual J-TEC Stockholders Meeting took place on June 23rd, and the Meeting approved the new BOD members. Updated Corporate Profile.
Jun. 24, 2009 Updated Top Message.
Apr. 30, 2009 Released "Financial Report for the FY2008".
Apr. 30, 2009 Updated Financial Highlight.
Mar. 30, 2009 Company report on J-TEC has been posted on the BIOTECH GATE website: Let's Interview Series - J-TEC (PDF file 192KB)
Feb. 13, 2009 Released "Summary of Financial Report for the 3 rd Quarter of FY ending March 2009".
Feb. 13, 2009 Updated Financial Highlight.
Jan. 7, 2009 On January 1 2009, J-TEC's autologous cultured epidermis "JACE" was listed as an item covered by the National Health Insurance in Japan. (Overview of National Health Insurance)
2008
Dec. 17, 2008 J-TEC has received reimbursement approval for the autologous cultured epidermis "JACE" in Japan. The reimbursement will start in Janurary 2009.
Nov. 14, 2008 Released "Summary of Financial Report for the 2 nd Quarter of FY ending March 2009".
Nov. 14, 2008 Updated Financial Highlight.
Aug. 12, 2008 Released "Summary of Financial Report for the 1 st Quarter of FY ending March 2009".
July 28, 2008 Introduced Prof. Howard Green of Harvard Medical School as J-TEC's research consultant.
June 25, 2008 New board of directors was approved at J-TEC's 10th annual meeting.
May 14, 2008 Released "Summary of Financial Report for FY2007".
2007
Dec. 21, 2007 J-TEC joined the Jasdaq Securities Exchange's Neo market for venture firms on December 21, 2007.
Nov. 1, 2007 On October 29, 2007, J-TEC officially received government approval to culture and sell autologous cultured epidermis JACE® for serious burns treatment in Japan.
Oct. 3, 2007 J-TEC got the go-ahead by the health ministry panel of the Ministry of Health, Labor and Welfare, for the manufacturing & sales approval of cultured epidermis in Japan.
2006
Nov. 21, 2006 Awarded the highest prize in the New Business Awards 2006, sponsored by the Chubu Economic Federation.
2005
Oct. 19, 2005 J-TEC awarded the Japan Bioventure Grand Prize, the top honor in the 4th Japan Bioventure Grand Prize awards.
Mar. 29, 2005 Sales launched of LabCyte, a human 3-D cultured epidermis model offering an alternative to animal testing.
2004
Feb. 2004 Obtained authorization to begin clinical trials of autologous cultured cartilage.
May 2004 Started multicenter clinical trials of autologous cultured cartilage.
Jun. 2004 Awarded President of the Science Council of Japan's Award at the 16th Awards for Excellence in Collaboration Between Industry, Academia, and Government.
Oct. 2004 Submitted application for manufacturing and sales approval of Autologous Cultured Epidermis.
Nov. 2004 Completed construction of new premises and moved in.
2003
Aug. 2003 Full-scale entry into cornea cultivation in collaboration with an Italian eye bank (The Veneto Eye Bank Foundation).
Sep. 2003 Started multicenter clinical trials of autologous cultured epidermis.
2002
Jan. 2002 Awarded a Special Incentive Award in the 15th Chunichi Industrial Technology Awards sponsored by the Chunichi Shimbun newspaper.
Mar. 2002 Obtained authorization to begin clinical trials of autologous cultured epidermis.
2001
Sep. 2001 Submitted application for government approval prior to a clinical trial of Autologous Cultured Cartilage.
2000
Nov. 2000 Awarded the Chubu Bureau of International Trade and Industry Prize in the New Business Awards Division of the Chubu New Business Awards, sponsored by the Chubu New Business Association.
Dec. 2000 Submitted application for government approval prior to a clinical trial of Autologous Cultured Epidermis.
1999
Sep. 1999 Relocated the head office to Miyakidadori, Gamagori.
Feb. 1999 Japan Tissue Engineering Co., Ltd established. Operations begun at Hama-cho, Gamagori.

Pagetop